Related Articles
Mismatch repair proteins expression and tumor‑infiltrating T‑cells in colorectal cancer
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma Corrigendum in /10.3892/or.2022.8411
Challenges in bioinformatics approaches to tumor mutation burden analysis
Comparative analysis of target gene exon sequencing by cognitive technology using a next generation sequencing platform in patients with lung cancer